NDRG2 Contributes to Cisplatin Sensitivity Through Modulation of BAK-to-Mcl-1 Ratio

Cell Death and Disease - United Kingdom
doi 10.1038/s41419-017-0184-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

ASNA-1 Activity Modulates Sensitivity to Cisplatin

Cancer Research
Cancer ResearchOncology
2010English

McL-1 and BCL-xL Sequestration of Bak Confers Differential Resistance to BH3-only Proteins

Cell Death and Differentiation
Cell BiologyMolecular Biology
2018English

Cisplatin Contributes to Programmed Death-Ligand 1 (PD-L1) Expression in Bladder Cancer Through ERK1/2 - AP-1 Signaling Pathway

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2019English

Glycolysis Inhibition Targets McL-1 to Restore Sensitivity of Lymphoma Cells to ABT-737-induced Apoptosis

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Overcoming Acquired Resistance to AZD9291, a Third Generation EGFR Inhibitor, Through Modulation of MEK/ERK-dependent Bim and McL-1 Degradation

Clinical Cancer Research
Cancer ResearchOncology
2017English

Cisplatin Resistance Coupled to Enhanced Sensitivity to Metabolic Interventions

Molecular and Cellular Oncology
Cancer ResearchMolecular Medicine
2018English

McL-1 Phosphorylation Without Degradation Mediates Sensitivity to HDAC Inhibitors by Liberating BH3-only Proteins

Cancer Research
Cancer ResearchOncology
2018English

McL-1: A Gateway to TRAIL Sensitization

Cancer Research
Cancer ResearchOncology
2008English

Pseudomonas Exotoxin A-Mediated Apoptosis Is Bak Dependent and Preceded by the Degradation of McL-1

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy